Literature DB >> 6626285

Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis.

G W Cannon, J R Ward, D O Clegg, C O Samuelson, T M Abbott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6626285     DOI： 10.1002/art.1780261015

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  17 in total

Review 1.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

Review 2.  Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review.

Authors:  Federico Rondon; Odilio Mendez; Nestor Spinel; Carlos Ochoa; Cristian Saavedra; Edgar Penaranda; Ignacio Garcia-Valladares; Luis R Espinoza; Antonio Iglesias-Gamarra
Journal:  Clin Rheumatol       Date:  2011-05-26       Impact factor: 2.980

3.  Low dose methotrexate pneumonitis in rheumatoid arthritis.

Authors:  S Louie; G A Lillington
Journal:  Thorax       Date:  1986-09       Impact factor: 9.139

Review 4.  Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

Authors:  S Tariq; S M Tariq
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

5.  Experience with low-dose methotrexate: toxicity, tolerability and effect on conventional patterns of drug therapy for inflammatory arthritis.

Authors:  M Nisar; L Carlisle; R Amos
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

Review 6.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

7.  Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis.

Authors:  A Schnabel; K Herlyn; C Burchardi; E Reinhold-Keller; W L Gross
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

8.  The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China.

Authors:  Yu-Qiong Zou; Ya-Song Li; Xiao-Nan Ding; Zhen-Hua Ying
Journal:  Rheumatol Int       Date:  2010-12-05       Impact factor: 2.631

Review 9.  Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature.

Authors:  M G Ridley; C S Wolfe; J A Mathews
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

10.  Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis.

Authors:  A Schnabel; E Reinhold-Keller; V Willmann; W L Gross
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.